Search results
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 hours agoLykos Therapeutics Provides Update on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD PR Newswire SAN JOSE, Calif., June 4, 2024 SAN JOSE ...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
NBC NEWS· 4 hours agoThe two votes — one for the treatment’s efficacy and one for its safety, by the agency’s...
FDA panel rejects first MDMA-based PTSD treatment
USA TODAY via Yahoo News· 1 hour agoOver 190 patients, who received doses of MDMA in addition to therapy, showed a significant reduction in PTSD scores compared to placebo. The FDA's staff reviewers on Friday ...
US health experts vote against MDMA as treatment for PTSD
AFP via Yahoo News· 2 hours agoA panel of US health experts convened by the Food and Drug Administration on Tuesday overwhelmingly...
FDA panel to evaluate psychedelic MDMA for treatment of PTSD for first time
Fox News· 11 hours agoA panel of advisers to the U.S. Food and Drug Administration will meet to discuss a therapy based on...
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 9 hours agoFrances Oldham Kelsey faced a tough choice between two job offers at different federal agencies in...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
WSB Radio· 9 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
MDMA Treatment for PTSD Gets Voted Against by FDA Advisers
TMZ· 3 hours ago4:22 PM PT -- And just like that, the FDA advisers who were mulling over using ecstasy to treat...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 12 hours agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
Associated Press· 10 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...